News

Q1 2025 Management View CEO Norman Schwartz noted that despite macroeconomic headwinds, the company is focusing on long-term ...
Among the most critical variables for ensuring reliable and reproducible qPCR data for gene expression studies is the appropriate use of assay controls. Download this article from Bio-Rad to learn ...
She found that unlike qPCR, the number of AAV vector genomes ... An example of this automation and integration effort is California-based Bio-Rad’s recently commercialized QX ONE platform ...
unsurpassed thermal cycler performance, unrivaled stand-alone functionality, and powerful yet easy-to-use software, the CFX96 Touch system is designed to advance your qPCR.
Inc., a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the SmartChip ND™ Real-Time PCR System, an automated, research-use-only (RUO), high-throughput qPCR solution for ...
Bio-Rad Laboratories Inc. (BIO.B) on Thursday reported first-quarter earnings of $64 million. On a per-share basis, the ...
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.54 per share, beating the Zacks Consensus Estimate of $1.73 per share. This compares to earnings of $2.29 per share a year ago. These ...
The CFX Connect real-time PCR detection system offers two-target analysis, excellent thermal cycler specifications, and the same reliable performance as the CFX96 Touch™ real-time PCR detection ...
Biodesix, Inc. and Bio-Rad Laboratories have collaborated on new research findings from the ctMoniTR Project, published in Clinical Cancer Research, which demonstrate a strong connection between ...